Vanguard Group Inc Age X Therapeutics, Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.33 - $0.74 $1,102 - $2,472	3,341 Added 0.48%	701,755 $266,000
Q4 2022 Feb 10, 2023	SELL	$0.54 - $0.68 $783 - $986	-1,450 Reduced 0.21%	698,414 $384,000
Q2 2022 Aug 12, 2022	SELL	$0.57 - $1.0 $658 - $1,156	-1,156 Reduced 0.16%	699,864 $403,000
Q1 2022 May 13, 2022	BUY	$0.65 - $1.2 $130 - $240	200 Added 0.03%	701,020 $599,000
Q3 2021 Nov 12, 2021	BUY	$0.93 - $1.54 $8,316 - $13,772	8,943 Added 1.29%	700,820 $659,000
Q2 2021 Aug 13, 2021	BUY	$1.14 - $1.77 $788,739 - $1.22 Million	691,877 New	691,877 $1.07 Million

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.